Nuvectis Pharma
NVCT
NVCT
12 hedge funds and large institutions have $10M invested in Nuvectis Pharma in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.21%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
2
Increased
9
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $4.49M | +$4.49M | +632,979 | New |
|
|
RC
2
Ronit Capital
London,
United Kingdom
| $3.99M | +$1.02M | +143,265 | +34% |
|
|
BWP
3
Baldwin Wealth Partners
Marion,
Massachusetts
| $943K | +$85.1K | +12,000 | +10% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $222K | +$52.8K | +7,474 | +31% |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $192K | +$27K | +3,804 | +16% |
|
6
BlackRock
New York
| $100K | +$48.6K | +6,805 | +95% |
|
7
State Street
Boston,
Massachusetts
| $83K | – | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $29K | +$19.8K | +2,773 | +217% |
|
9
UBS Group
Zurich,
Switzerland
| $2K | +$1.44K | +158 | +255% |
|
10
Morgan Stanley
New York
| $1K | +$5 | +1 | +0.5% |
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1K | +76 | New |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$393K | -35,069 | Closed |
|